United BioSource Corporation

Blue Bell, United States Founded: 2003 • Age: 23 yrs Acquired By Avista Capital Partners
Pharmaceutical support services

About United BioSource Corporation

United BioSource Corporation is a Healthcare company based in Blue Bell (United States) founded in 2003, and was acquired by Avista Capital Partners in November 2017. Pharmaceutical support services. United BioSource Corporation has raised $278 million across 3 funding rounds from investors including J P Morgan, PNC and Express Scripts. United BioSource Corporation has completed 5 acquisitions, including BioCor, Cognitive Drug Research and Examoto. Its website ubc.com draws about 279 thousand monthly visits. United BioSource Corporation offers products and services including Evidence Development, Safety and Risk Management, Patient Access, and Technology Solutions. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Late Stage. Its legal entity is UBC LATE STAGE (UK) LIMITED. Its competitors include Launch Therapeutics, Concentrics Research and Nexus Biosciences.

Company details

United BioSource Corporation provides pharmaceutical support services. Services include clinical development and late stage clinical research, trial management, risk monitoring, risk evaluation and mitigation strategies, risk management plans, reimbursement patient assistance, along with support programs designed to enhance patients adherence. It also offers CLÆRITY and SÆfetyworks web based analytical softwares and has partnered with Accredo Specialty Pharmacy and CuraScript Specialty Distribution to help pharmaceutical and biotech manufacturers maximize product access and commercialization.

  • Headquarters Blue Bell, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website ubc.com
  • Social LinkedIn X
  • Acquired by Avista Capital Partners (Nov 2017)
  • Legal Name Ubc Late Stage (Uk) Limited
Key Metrics
  • Total Equity Funding
    $278M (USD)

    in 3 rounds

  • Latest Funding Round
    $150M (USD), Debt – Conventional

    Jul 2010

  • Investors
    J P Morgan

    & 9 more

  • Investments & Acquisitions
    BioCor

    & 4 more

  • Acquired by
    Avista Capital Partners

    & 1 more

    (Nov 2017)

Products & Services of United BioSource Corporation

United BioSource Corporation offers a comprehensive portfolio of products and services, including Evidence Development, Safety and Risk Management, Patient Access, and Technology Solutions.

Evidence Development
Research Services

Solutions for generating real-world evidence and analytics.

Safety and Risk Management
Risk Mitigation

Services to manage product safety and compliance.

Patient Access
Access Solutions

Programs for improving therapy affordability and adherence.

Technology Solutions
Tech Platforms

Tools to accelerate innovation and data insights.

Funding Insights of United BioSource Corporation

United BioSource Corporation has successfully raised a total of $278M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $150 million completed in July 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $278M
  • Total Rounds 3
  • Last Round Debt – Conventional — $150M
  • First Round $153M

    (Dec 2003)

  • Investors Count 8

All 3 funding rounds of United BioSource Corporation with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2010$150MDebt – Conventional––
Oct 2009$125MPrivate Equity Round––
Dec 2003$153MPrivate Equity Round––
Valuation history

10 investors in total: 10 institutional.

Investors in United BioSource Corporation

United BioSource Corporation has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include J P Morgan, PNC and Express Scripts.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity investments are directed toward growth-stage companies.
berkshirepartners.comBoston, United States
Early-stage US tech startups are invested in by Grotech Ventures.
grotech.comArlington, United States
whitney.com
Venture capital investments are made in disruptive growth companies.
oakvc.comGreenwich, United States
Venture capital investments are offered to startups by NEA.
nea.comMenlo Park, United States
Diverse financial services and online banking are provided to clients.
1852wellsfargo.comSan Francisco, United States
Comprehensive financial services are provided to corporations and individuals.
1799jpmorgan.comNew York, United States
Commercial banking and financing services are provided by PNC.
1845pnc.comPittsburgh, United States
Private equity investments are focused on the United States market.
avistacap.comNew York, United States
Pharmacy benefit management services are delivered through SaaS platforms.
1986express-scripts.comSt. Louis, United States
Premium access

Investor details for United BioSource Corporation

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of United BioSource Corporation

246 people are tracked at United BioSource Corporation (76 in leadership, 170 in team).

NameRoleGroup
Patrick Lindsay
Executive Vice PresidentLeadership
Ronald Lacy
Vp, Products & InnovationLeadership
Laurent Vidal
Associate Director, PharmacovigilanceLeadership
Milena T.
Project DirectorLeadership
Marci Gott Bsn
Executive Director Patient ServicesLeadership
Patty Frank
Vice President, Pricing StrategyLeadership
Aaron Berger
Head of Evidence Development SolutionsLeadership
Judy Lytle
Executive Director, Evidence Development (medical Affairs & Rwe)Leadership
Jeff Lowry
Senior Director Of Software EngineeringLeadership
Eileen Moran
Executive Director, Evidence Development OperationsLeadership
Ida Pranger
Executive Director Human ResourcesLeadership
Anna Kowalczyk
Senior Director Project ManagentLeadership
Geraldine Aubes
Executive Director, Global Head Of PharmacovigilanceLeadership
Christopher Foley
Director Of Business DevelopmentLeadership
Miriana Wennekes
Director Clinical Research Including Line ManagementLeadership
Anne Santovito
Executive Director, REMS Business Strategy And OperationsLeadership
Inci Porter
Senior Director, Account ManagementLeadership
Danilo A. Belloso
Director Of Business DevelopmentLeadership
Susan Thompson
DirectorLeadership
Glynis Daniel-Archibald M.D./Mba/Pmp
Executive DirectorLeadership

226 more people are available in the full profile.

Premium access

Complete people profiles for United BioSource Corporation

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by United BioSource Corporation

United BioSource Corporation has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include BioCor, Cognitive Drug Research and Examoto.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
IT services are provided to the healthcare sector.
examoto.comBryn Mawr, United States2012Jul 2022••••
Software solutions for pharmacovigilance reporting and analysis are provided.
prosanos.comHarrisburg, United States2000Nov 2010••••
Automated cognitive function assessment for clinical trials is provided.
cognitivedrugresearch.comGoring, United Kingdom1986Sep 2009••••
Multi-speciality healthcare services are delivered by Biocor hospital in Brazil.
biocor.com.brNova Lima, Brazil1985Nov 2006••••
Pharmacy benefits are managed for healthcare clients by Pharmastar.
pharmastarpbm.comEau Claire, United States1997Apr 2005••••
Premium access

Complete acquisition details for United BioSource Corporation

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of United BioSource Corporation

10 dated milestones of United BioSource Corporation across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded United BioSource Corporation is founded.
  2. Funding First funding round of $153.0M.
  3. Acquisition Acquires Pharmastar.
  4. Acquisition Acquires BioCor.
  5. Acquisition Acquires Cognitive Drug Research.
  6. Funding Latest funding round, Debt – Conventional, of $150.0M.
  7. Exit Acquired by Express Scripts.
  8. Acquisition Acquires ProSanos.
  9. Exit Acquired by Avista Capital Partners.
  10. Acquisition Acquires Examoto.

Competitors of United BioSource Corporation

United BioSource Corporation has 3 listed competitors in our database. They include Launch Therapeutics, Concentrics Research and Nexus Biosciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
launchtx.com2022Boston, United States
Late-stage clinical development services are provided for biopharma companies.
concentricsresearch.com1999Indianapolis, United States47
Late-stage (Phase II-IV trials) CRO
nexusbiosciences.com2012Carlsbad, United States
CRO specializing in late stage, observational and post-approval studies
Premium access

Detailed competitors of United BioSource Corporation

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of United BioSource Corporation

The website of United BioSource Corporation (ubc.com) receives about 279.3K visits a month and ranks #178,109 among all websites worldwide, #5,672 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    279.3K

    ▲ 5% vs previous month

  • Unique visitors
    127.6K

    per month

  • Global rank
    #178,109

    among all websites

  • Category rank
    #5,672

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with United BioSource Corporation. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ipledgeprogram.com
100%
#93,084View details
bracketglobal.com
83%
1.1K#14,907,063View details
syneoshealth.com
70%
199.6K#198,509View details
iqvia.com
70%
1.2M#45,953View details
visualdx.com
53%
286.6K#137,622View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 27 similar websites and full traffic analytics for United BioSource Corporation

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 27 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as United BioSource Corporation (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about United Biosource Corporation

Premium access

Complete news archive for United BioSource Corporation

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about United BioSource Corporation

United BioSource Corporation was founded in 2003.

United BioSource Corporation is headquartered in Blue Bell, United States. It is registered at Blue Bell, Pennsylvania, United States.

United BioSource Corporation is a funded company, having raised a total of $278M across 3 funding rounds to date. The company's 1st funding round was a Private Equity Round of $153M, raised on Dec 2003.

United BioSource Corporation provides pharmaceutical support services. Services include clinical development and late stage clinical research, trial management, risk monitoring, risk evaluation and mitigation strategies, risk management plans, reimbursement patient assistance, along with support programs designed to enhance patients adherence. It also offers CLÆRITY and SÆfetyworks web based analytical softwares and has partnered with Accredo Specialty Pharmacy and CuraScript Specialty Distribution to help pharmaceutical and biotech manufacturers maximize product access and commercialization.

United BioSource Corporation's top competitors include Concentrics Research, Nexus Biosciences and Launch Therapeutics.

United BioSource Corporation offers Evidence Development, Safety and Risk Management, Patient Access, and Technology Solutions.

United BioSource Corporation has made 5 acquisitions, including BioCor, Cognitive Drug Research, and Examoto.

United BioSource Corporation has 10 investors. Key investors include J P Morgan, PNC, Express Scripts, Wells Fargo, and Berkshire Partners.

United BioSource Corporation operates through Ubc Late Stage (Uk) Limited.

Yes. United BioSource Corporation was acquired by Avista Capital Partners in November 2017.

The website of United BioSource Corporation receives about 279 thousand visits a month and ranks #178,109 among all websites worldwide.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available